Abstract
Traditionally, benign and malignant diseases of the skeletal system have been evaluated with radiological investigations like X-ray, CT scan, or MRI. These have established themselves as modalities of choice because of wide availability and excellent anatomical details they provide. X-ray and CT scan have been able to provide excellent images of cortical bone while MRI depicts details of bone marrow and associated soft tissue like no other imaging modality can. In the last decade or so, there has been tremendous interest and advances in applications of positron emission tomography (PET) in the field of oncology. Particularly, 2-fleuro-2-deoxy-glucose (FDG) PET-CT has become a backbone of oncological imaging for various cancers, including the bone and bone marrow tumors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
For Further Reading
Bartel TB, Haessler J, Brown TL, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood. 2009;114:2068–76.
Cheng G, Kwee TC, Basu S, Alavi A. Critical considerations on the combined use of 18F-FDG and 18F-fluoride for PET assessment of metastatic bone disease. Eur J Nucl Med Mol Imaging. 2013;40:1141–5.
Eubank WB, Mankoff DA. Current and future uses of positron emission tomography in breast cancer imaging. Semin Nucl Med. 2004;34:224–40.
Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med. 2005;46:1356–67.
Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004;34:274–92.
Watanabe H, Inoue T, Shinozaki T, et al. PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET. Eur J Nucl Med. 2000;27:1509–17.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer India
About this chapter
Cite this chapter
Pawaskar, A., Basu, S. (2015). Role of PET-CT in Malignant Involvement of Bone and Bone Marrow. In: Das, B. (eds) Positron Emission Tomography. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2098-5_16
Download citation
DOI: https://doi.org/10.1007/978-81-322-2098-5_16
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2097-8
Online ISBN: 978-81-322-2098-5
eBook Packages: MedicineMedicine (R0)